In this episode, host Shikha Jain, MD, speaks with Sean Bohen, MD, about how cancer therapies are changing how oncology can be discussed, shifting from clinical to industry work and more.
• Welcome to another exciting episode of Oncology Overdrive :58
• About Bohen 1:04
• The interview 1:30
• Tell us about your journey. How did you become an oncologist, and how did you make the transition into working in the pharmaceutical industry? 1:51
• How did you end up at Olema Oncology after working with other pharmaceutical companies? What was your decision-making process to focus on the industry part of your career? 3:44
• Tell us more about what Olema Oncology does and what your role is there. 6:30
• What do you see coming down the pipeline for breast cancer research and innovation? … What do you think Olema will contribute to that space? 8:58
• Bohen and Jain on the ways in which new treatments have resulted in shifting conversations around cancer care and patient quality of life. 12:45
• If someone in fellowship is interested in working in industry, pharmaceuticals or scientific development, what are the most effective ways to get into this space? 18:21
• Jain and Bohen on changing the mindset and misconceptions around moving between clinical, academic and industry work within the field and after fellowship. 20:52
• What do you see happening in the oncology landscape twenty years from now? 25:46
• If someone could only listen to the last two minutes of this episode, what would you want them to take away? 29:19
• How to contact Bohen 30:54
• Thanks for listening 31:52
Sean Bohen, MD, is the President and CEO of Olema Oncology.
We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Bohen can be reached at olema.com.
Disclosures: Jain and Bohen report no relevant financial disclosures.